• Mashup Score: 2

    Do the potential benefits of thrombolytic drugs for acute stroke outweigh the potential harms? In a guest blog, Drs W. Ken Milne and Daniel Fatovich examine this issue in light of new evidence.

    Tweet Tweets with this article
    • @masterlongevity @ProfRobHoward @DanClintonRN @ajlees @gregggonsalves @PhilAlz @DrTFromKC @smead2 @nvillain_alz @DavidJonesBrain @LonSchneiderMD @AlbertoEspay @Kariem_Ezzat @MadhavThambiset @matthewherper @seb_walsh @JosephTherr @dmrind @Scott_M_Reid @EWidera @RenegadeSynapse @LogarithmicDis @KasperKepp @Jennife10651535 @pxrobbo @MemoryDoc @metapredict @CorriveauNick @eturnermd1 @kateeeemily @StefanoSensi14 @VincentPlanche @ayton_scott @reshmagar @KarlHerrup @GiovanniFrisoni @macesari @geoperry @samgandy @Gill_Livingston @andrea_sturchio @AndaloussiLab @rkhamsi @r_merrick @schrag_matthew @kathy_y_liu @naomikresge @MedicareGov @JAMANetwork As @TheSGEM recently wrote abt tPA "Ironically, a common neurological treatment tPA is one of those ideas that many emergency physicians consider to be wrong while most neurologists consider it to be right, no matter how much research is done" https://t.co/o3gW7oGC7V